Literature DB >> 18556453

Onset of psoriasis with psoriatic arthropathy during rituximab treatment of non-Hodgkin lymphoma.

F Mielke, J Schneider-Obermeyer, T Dörner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556453     DOI: 10.1136/ard.2007.080929

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  19 in total

Review 1.  Potential importance of B cells in aging and aging-associated neurodegenerative diseases.

Authors:  Arya Biragyn; Maria Aliseychik; Evgeny Rogaev
Journal:  Semin Immunopathol       Date:  2017-01-12       Impact factor: 9.623

Review 2.  Hyperkeratotic Skin Adverse Events Induced by Anticancer Treatments: A Comprehensive Review.

Authors:  Maria Vastarella; Gabriella Fabbrocini; Vincent Sibaud
Journal:  Drug Saf       Date:  2020-05       Impact factor: 5.606

3.  A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand.

Authors:  Avijit Ray; Sreemanti Basu; Calvin B Williams; Nita H Salzman; Bonnie N Dittel
Journal:  J Immunol       Date:  2012-02-24       Impact factor: 5.422

Review 4.  Adverse reactions to biologic agents and their medical management.

Authors:  Onur Boyman; Denis Comte; François Spertini
Journal:  Nat Rev Rheumatol       Date:  2014-08-12       Impact factor: 20.543

5.  IL-10+ Innate-like B Cells Are Part of the Skin Immune System and Require α4β1 Integrin To Migrate between the Peritoneum and Inflamed Skin.

Authors:  Skye A Geherin; Daniela Gómez; Raisa A Glabman; Gordon Ruthel; Alf Hamann; Gudrun F Debes
Journal:  J Immunol       Date:  2016-02-05       Impact factor: 5.422

Review 6.  Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.

Authors:  Laurie S Davis; Andreas M Reimold
Journal:  Rheumatology (Oxford)       Date:  2017-04-01       Impact factor: 7.580

Review 7.  A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Avijit Ray; Monica K Mann; Sreemanti Basu; Bonnie N Dittel
Journal:  J Neuroimmunol       Date:  2010-12-10       Impact factor: 3.478

Review 8.  Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders.

Authors:  M C Levesque
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

9.  A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency.

Authors:  Mariam Hammadi; Jacques-Olivier Pers; Christian Berthou; Pierre Youinou; Anne Bordron
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

10.  Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L.

Authors:  Monica Bodogai; Catalina Lee Chang; Katarzyna Wejksza; Jinping Lai; Maria Merino; Robert P Wersto; Ronald E Gress; Andrew C Chan; Charles Hesdorffer; Arya Biragyn
Journal:  Cancer Res       Date:  2013-01-30       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.